/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Strata Critical Medical (SRTA) generated about $256 million in revenue and $40 million in net income (a 15.7% net margin) over the trailing twelve months, growing at roughly 53.1% a year. Figures are from SEC filings; this is analysis, not investment advice.
Strata Critical Medical generated about $256 million in revenue over the trailing twelve months. Revenue has grown at roughly 53.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Yes, Strata Critical Medical reported about $40 million in net income over the trailing twelve months, a net profit margin of roughly 15.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
Strata Critical Medical runs a gross margin of about 21.3%, an operating margin of about -8.0%, a net margin of about 15.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Strata Critical Medical's revenue has compounded at roughly 53.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside SRTA's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 4 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 5 Aug 2026. How this is calculated.
Fiscal year ends Dec.